S19 An update on therapeutic strategies and clinical trials in dementia

Date: Tuesday 21 June
Time: 15.40 - 16.55
Stream: New science

This session will review potential treatment strategies for dementia based on inflammation, protein handling, glucose metabolism and tau phosphorylation and clinical trials which target these.

Chair: Professor John O'Brien, University of Cambridge

Inflammation as a therapeutic target in alzheimer's disease

Dr Vanessa Raymont, University of Oxford

Lithium and other inhibitors of tau phosphorylation

Dr Ross Dunne, University of Manchester

Protein production, degradation and glucose metabolism

Dr Ben Underwood, University of Cambridge 


Please email congress@rcpsych.ac.uk or call 020 8618 4120 with any enquiries.